Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, Maryland 21201-1140, USA.
J Biol Chem. 2012 May 25;287(22):18342-50. doi: 10.1074/jbc.M112.359265. Epub 2012 Apr 9.
Heme utilization by Pseudomonas aeruginosa involves several proteins required for internalization and degradation of heme. In the following report we provide the first direct in vivo evidence for the specific degradation of extracellular heme to biliverdin (BV) by the iron-regulated HemO. Moreover, through isotopic labeling ((13)C-heme) and electrospray ionization-MS analysis we have confirmed the regioselectivity and ratio of (13)C-δ and β-BV IX (70:30) is identical in vivo to that previously observed for the purified protein. Furthermore, the (13)C-BV IXδ and BV IXβ products are effluxed from the cell by an as yet unidentified transporter. Conversion of extracellular heme to BV is dependent solely on the iron-regulated HemO as evidenced by the lack of BV production in the P. aeruginosa hemO deletion strain. Complementation of P. aeruginosa ΔhemO with a plasmid expressing either the wild type HemO or α-regioselective HemO mutant restored extracellular heme uptake and degradation. In contrast deletion of the gene encoding the cytoplasmic heme-binding protein, PhuS, homologs of which have been proposed to be heme oxygenases, did not eliminate (13)C-BV IXδ and IXβ production. In conclusion the metabolic flux of extracellular heme as a source of iron is driven by the catalytic action of HemO.
铜绿假单胞菌利用血红素涉及到几种将血红素内化和降解所需的蛋白。在本报告中,我们首次提供了铁调节蛋白 HemO 特异性降解细胞外血红素为胆绿素 (BV) 的直接体内证据。此外,通过同位素标记 ((13)C-血红素) 和电喷雾电离-MS 分析,我们已经证实了纯化蛋白中观察到的 (13)C-δ 和 β-BV IX (70:30) 的区域选择性和比值在体内是相同的。此外,(13)C-BV IXδ 和 BV IXβ 产物通过尚未鉴定的转运蛋白从细胞中流出。细胞外血红素向 BV 的转化仅依赖于铁调节蛋白 HemO,这可以从铜绿假单胞菌 hemO 缺失株中缺乏 BV 产生这一事实得到证明。用表达野生型 HemO 或 α-区域选择性 HemO 突变体的质粒补充 P. aeruginosa ΔhemO,恢复了细胞外血红素的摄取和降解。相比之下,编码细胞质血红素结合蛋白 PhuS 的基因缺失,其同源物被提议为血红素加氧酶,并没有消除 (13)C-BV IXδ 和 IXβ 的产生。总之,作为铁源的细胞外血红素的代谢通量是由 HemO 的催化作用驱动的。